Accordion title open

Image Description

Accordion title close

Image Description

A graphic that shows the percentage of patients who had the composite endpoint of A1C less than or equal to 6.5%, weight reduction greater than or equal to 10%, and no clinically significant or severe hypoglycemia with Mounjaro 15 mg or maximum tolerated dose plus metformin or intensified conventional care plus metformin. 54.2% of patients had the composite endpoint with Mounjaro 15 mg or maximum tolerated dose plus metformin and 21.1% with intensified conventional care plus metformin.